Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT06369441 Not yet recruiting - Cancer Clinical Trials

Collection of Biological Specimens and Associated Health Information

Start date: April 2024
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to collect blood samples from a large number of individuals with cancer to create a database for researchers to use in future studies. Researchers may use this database to discover new ways to detect and treat cancer and other diseases. Future studies may use stored blood samples to discover how genes affect health and disease.

NCT ID: NCT06368947 Recruiting - Cancer Clinical Trials

Therapeutic Play on Pain Tolerance and Emotion Regulation in Children

Start date: March 29, 2024
Phase: N/A
Study type: Interventional

The research is a randomized controlled experimental study. The population of the research will consist of 10-18 year old children who were diagnosed with acute lymphoblastic leukemia and received chemotherapy, who were admitted to the Children's Hematology Clinic of Adana City Training and Research Hospital between 19.05.2024 and 19.05.2025. Therapeutic play sessions will occur over a 4-week period during chemotherapy treatment.

NCT ID: NCT06367959 Recruiting - Cancer Clinical Trials

Health Benefits of Writing Therapy Among Asian American Cancer Survivors

Start date: July 27, 2023
Phase: N/A
Study type: Interventional

To learn more about participant experience as a Asian American immigrant breast cancer survivor and how writing about participant experiences may affect participant's health.

NCT ID: NCT06361862 Recruiting - Cancer Clinical Trials

Does Continuous Vital Sign Monitoring Increase Investigations and Interventions in Complication-free Patients?

WARD-OT
Start date: January 1, 2024
Phase: N/A
Study type: Interventional

This aim of this study is to investigate whether active alerts during CVSM result in an increased number of diagnostic tests and treatments in complication free patients, hypothesizing that more interventions are performed in the CVSM-group than standard of care (EWS) group.

NCT ID: NCT06360471 Recruiting - Cancer Clinical Trials

Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer

Start date: October 1, 2023
Phase:
Study type: Observational [Patient Registry]

To explore whether there is a significant difference in the cumulative live birth rate and maternal and child health outcomes between cancer patients who undergo or do not undergo fertility preservation before receiving anti-tumor treatment and non-cancer patients who undergo assisted reproductive technology treatment/natural pregnancy. This study will be conducted in the Clinical Center of Reproductive Medicine, First Affiliated Hospital of Nanjing Medical University. 2800 women diagnosed with malignant cancers who has desire to reproduce will be enrolled in this study. Statistical analysis of the data will be performed.

NCT ID: NCT06357000 Completed - Clinical trials for Coronary Artery Disease

Time From PCI to Cancer Surgery and Cardiovascular and Oncologic Outcomes

Start date: January 1, 2008
Phase:
Study type: Observational

To evaluate the association between time from PCI to cancer surgery and cardiovascular and oncologic outcomes in early-stage cancer patients, A retrospective, population-based cohort study was conducted using data from the Korean National Health Insurance Service (K-NHIS) database.

NCT ID: NCT06356363 Not yet recruiting - Cancer Clinical Trials

Development of a Questionnaire on Patients' Perception of Their Oncology Care Pathway (Onco-PREMs)

OncoPREMs
Start date: June 1, 2024
Phase:
Study type: Observational

Healthcare systems are evolving, giving increasing prominence to the patient-centered model, accompanied by objective and perceived outcomes. PREMs (Patient Reported Experience Measures) are used to assess how patients feel about their experience of care. PREMs enable patients to take an active role in their own care, and enable healthcare establishments to identify areas for improvement that can be incorporated into their quality processes. In oncology, the collection of patient-perceived quality regarding their care pathway would enable better coordination of their care. While a few initiatives have emerged in the field of PREMs, the development of a reliable questionnaire assessing patient perception of their care pathway in oncology remains a challenge.

NCT ID: NCT06355245 Recruiting - Cancer Clinical Trials

MEDECA - Markers in Early Detection of Cancer

MEDECA
Start date: March 1, 2018
Phase:
Study type: Observational

Early diagnosis of cancer is key for improving patient outcomes, but cancers are difficult to diagnose if patients present with unspecific symptoms. The principal objective of the MEDECA (Markers in Early Detection of Cancer) study is to identify a multi-analyte blood test that can detect and map occult cancer within a mixed population of patients presenting with serious but unspecific symptoms. The study will include 1500 patients referred to the Diagnostic Center at Danderyd Hospital (DC DS), a multidisciplinary diagnostic center referral pathway for patients with radiological findings suggestive of metastasis without known primary tumor or suspicion of serious but unspecific symptoms. Blood samples are collected prior to a standardized and extensive cancer diagnostic work-up, including an expanded panel of biochemical analyses and extensive imaging such as computed tomography or magnetic resonance investigations. In collaboration with world-leading international scientists, the blood samples will be analyzed for a panel of novel and established blood biomarkers predictive of an underlying cancer, including markers of neutrophil extracellular traps, circulating tumor DNA, platelet mRNA profiling, affinity-based proteomics and nuclear magnetic resonance metabolomics. The diagnostic accuracy of the blood biomarkers with respect to cancer detection during the diagnostic work-up will be analyzed through machine learning.

NCT ID: NCT06353178 Recruiting - Cancer Clinical Trials

Building Empowerment and Coping Outcomes for caNcer Patients, Survivors and Their Caregivers

BEACON
Start date: April 8, 2024
Phase: N/A
Study type: Interventional

Cancer has a psychological, emotional and social impact beyond a patient's physical health. This study examines three new online peer mental-wellness support program for cancer patients, survivors or their caregivers. Each program teaches evidence-based skills, in the context of that groups lived experience, to manage the emotional impact of cancer. This study examines the impact of that program.

NCT ID: NCT06350214 Completed - Cancer Clinical Trials

Physical Activity and Nutrition in Cancer Survivors

Start date: January 1, 2007
Phase:
Study type: Observational

This study aims to investigate the independent and combined associations between physical activity and nutrition condition with mortality among cancer survivors.